0001213900-26-035467
SEC filingBio Essence Corporation reported a significant turnaround in FY 2025, generating net income of $896,197 from continuing operations, compared to a net loss of $1,565,721 in FY 2024. This improvement was driven by a substantial increase in total revenues to $1,897,566 (up 485.78% YoY), primarily from OEM service revenue of $1,896,350, while product sales ceased. Gross profit surged to $1,428,413 (75.28% margin) from $217,077 (67.01% margin) in the prior year. However, the company faces substantial doubt about its ability to continue as a going concern, with an accumulated deficit of $9,553,073, working capital deficit of $2,016,834, and current liabilities of $2,439,211 exceeding current assets of $422,377. The company's liquidity relies heavily on shareholder loans, and it estimates needing $1.2 million to continue operations for the next 12 months.
Bio Essence Corporation achieved a dramatic financial turnaround in FY 2025, reporting net income of $896,197 from continuing operations compared to a net loss of $1,565,721 in FY 2024. This $2.46 million improvement was driven by a 485.78% increase in total revenues to $1,897,566. The company's strategic shift to OEM services proved successful, with OEM revenue reaching $1,896,350 (99.94% of total revenue), while product sales ceased entirely. Operating income improved to $900,011 from an operating loss of $459,438 in the prior year. However, the company faces significant financial challenges, including an accumulated deficit of $9,553,073, working capital deficit of $2,016,834, and current liabilities of $2,439,211 exceeding current assets of $422,377, raising substantial doubt about its ability to continue as a going concern.
Revenue composition shifted dramatically in FY 2025, with OEM services becoming the exclusive revenue driver at $1,896,350 (570.68% increase from $282,752 in FY 2024). Product sales declined to zero from $37,415 in the prior year, reflecting the company's strategic pivot away from direct product sales. Shipping and delivery income decreased to $1,216 from $3,773. Management attributed the revenue growth to higher volumes of OEM service orders, including large orders from three new major customers. The company's discontinued operations generated $153,865 in revenue during FY 2024 but contributed no revenue in FY 2025 following the sale of subsidiaries.
Gross margin improved significantly to 75.28% in FY 2025 from 67.01% in FY 2024, with gross profit increasing to $1,428,413 from $217,077. This improvement resulted from the higher-margin OEM service business replacing lower-margin product sales. Operating expenses decreased to $528,402 from $676,515, primarily due to reduced general and administrative expenses ($497,809 vs. $676,515), including decreased office rent and property tax expenses. Operating margin reached 47.43%, a substantial improvement from the -141.83% operating margin in FY 2024. Other expenses decreased dramatically to $3,014 from $1,105,483, primarily due to the absence of a $1,050,940 impairment loss on ROU assets recorded in the prior year.
Operating cash flow from continuing operations was strong at $1,569,753, up from $639,817 in FY 2024. However, financing activities used $1,571,124, primarily for loan repayments to shareholders ($1,853,800) and loans to shareholders ($485,173). The balance sheet shows significant financial strain: total assets of $422,377 are dwarfed by total liabilities of $2,500,000, resulting in stockholders' deficit of $2,077,623. Current assets of $422,377 include cash of $1,000, accounts receivable of $23,000, and a loan to shareholder of $385,173. Current liabilities of $2,439,211 include customer deposits of $849,000, operating lease liabilities of $1,500,000, and loans from shareholders of $1,200,000. The company's current ratio is 0.17:1.
Management has expressed substantial doubt about the company's ability to continue as a going concern and estimates needing $1.2 million to continue operations for the next 12 months. The company plans to increase income by strengthening its sales force, implementing sales incentive programs, and increasing marketing activities. Management also intends to raise additional funds through private or public offerings or loans from banks. The company faces significant legal contingencies, including a $1.5 million claim from Stason Industrial Corporation for alleged breach of contract related to lease obligations. The company's future depends on its ability to generate sufficient revenue and secure additional financing, with no assurance that such funding will be available on acceptable terms.